Home › Calculator › SNZZF Dividend Calculator 2026
SNZZF Dividend DRIP Calculator 2026
512.82% YieldHealthcareSenzime AB (publ) · OTC
Price: $0.39 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When SNZZF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your SNZZF snowball 📈
$10,000 in SNZZF → $243.58M in 10 years · $101,146.11/month
About Senzime AB (publ) (SNZZF) — Dividend Analysis 2026
Based in Uppsala, Sweden, Senzime AB (publ) is a medical technology company founded in 1999, specializing in the development and commercialization of advanced patient monitoring systems. These systems are designed to oversee individuals under anesthesia across a wide geographic reach, including Europe, Oceania, Asia, Canada, and the United States. A key offering is the TetraGraph monitor, which precisely stimulates, measures, analyzes, and displays muscle function for surgical patients administered neuromuscular blocking agents. The system includes the TetraSens electrode array, featuring two proximal stimulating electrodes for precise recording and reference. Its TetraConnect data management portal allows clinicians to easily access, view, and export records from the TetraGraph in PDF or Excel format. Additionally, TetraGraph Device Connectivity facilitates the transfer of data from the monitor to other patient monitoring systems. A specific TetraGraph Philips Interface enables the direct transmission of neuromuscular monitoring parameters (TOFC, TOFR, PTC, and TOF bars) to Philips patient monitors, displaying readings on the Philips Intellivue Monitor. The company's portfolio also includes the CliniSenz Analyzer, developed for continuous postoperative patient surveillance in hospital settings. Furthermore, the Onzurf Probe is a sterile, CE-marked, single-use micro-dialysis product that allows for continuous sampling from gastrointestinal organs like the esophagus, stomach, and liver. Senzime AB (publ) has entered into a strategic license and connectivity agreement with Masimo. This collaboration focuses on developing and commercializing the TetraGraph Smart Cable Module, designed to connect directly with Masimo's Root monitoring system and its digital hubs for seamless integration with hospital clinical information systems and electronic health records.
Compare SNZZF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full SNZZF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open SNZZF position with:
🌍 SNZZF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold SNZZF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 512.82% | 510.02% | $51,282 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 435.90% | 433.10% | $43,590 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 410.26% | 407.46% | $41,026 / yr |
| 🇬🇧 UK ISA | 0% | 512.82% | 510.02% | $51,282 / yr |
| 🇬🇧 UK Taxable | 8.75% | 467.95% | 465.15% | $46,795 / yr |
| 🇨🇦 TFSA | 0% | 512.82% | 510.02% | $51,282 / yr |
| 🇨🇦 CA Taxable | 25% | 384.62% | 381.81% | $38,462 / yr |
| 🇦🇺 Super (pension) | 15% | 435.90% | 433.10% | $43,590 / yr |
| 🇦🇺 AU Taxable | 30% | 358.97% | 356.17% | $35,897 / yr |
| 🇩🇪 DE Taxable | 26.375% | 377.56% | 374.76% | $37,756 / yr |
| 🇫🇷 FR Taxable | 30% | 358.97% | 356.17% | $35,897 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 SNZZF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 SNZZF Dividend Payment Schedule
SNZZF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 SNZZF vs Healthcare Benchmarks
How SNZZF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SNZZF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ SNZZF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SNZZF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Senzime AB (publ) (SNZZF) is currently trading at $0.39, 86% below its 52-week high. The current dividend yield is 512.82% based on an annual payout of $2.00 per share.
SNZZF (Senzime AB (publ)) — 512.82% Dividend Yield Analysis
Senzime AB (publ) (SNZZF) is a healthcare stock currently trading at $0.39 with a dividend yield of 512.82%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (512.82%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.